In April 2020, the FDA requested the removal of Zantac and other ranitidine medications from the market. This removal was sparked by new research indicating the presence of NDMA, a harmful probable ...

J Gastroenterol Hepatol. 2005;20(1):11-25. Parenteral PPI preparations have been available in European and Asian countries for many years. Recently, parenteral pantoprazole has been approved for ...

GSK launched Zantac in 1981 and it was first approved for sale in the US in 1983 as a prescription medication. It went on to become the world's best-selling drug, with annual sales in excess of $1bn.

The understanding of key principles in pharmacology is essential to the clinical and research nuclear medicine practitioner. The scope of practice of the nuclear medicine technologist requires ...